-
NUMBER OF INSIDER BUYING
(Last 12 Months)
2 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
2 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$18.48 M -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$18,819
Verve Therapeutics, Inc. Insider Transactions
Verve Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
GV 2017 GP, L.L.C.
Director |
Sell | 25,535 @ $33.14 | $846,189 | 1,755 | 11/03/2022 | 11/04/2022 | |
|
Yeshwant Krishna
Director |
Sell | 9,350 @ $34.78 | $325,150 | 4,377,500 | 11/02/2022 | 11/04/2022 | |
|
Yeshwant Krishna
Director |
Sell | 10,372 @ $36.28 | $376,282 | 4,367,128 | 11/02/2022 | 11/04/2022 | |
|
Yeshwant Krishna
Director |
Sell | 8,930 @ $36.78 | $328,401 | 4,358,198 | 11/02/2022 | 11/04/2022 | |
|
GV 2017 GP, L.L.C.
Director |
Sell | 9,350 @ $34.78 | $325,150 | 4,377,500 | 11/02/2022 | 11/04/2022 | |
|
GV 2017 GP, L.L.C.
Director |
Sell | 10,372 @ $36.28 | $376,282 | 8,930 | 11/02/2022 | 11/04/2022 | |
|
GV 2017 GP, L.L.C.
Director |
Sell | 8,930 @ $36.78 | $328,401 | 4,358,198 | 11/02/2022 | 11/04/2022 | |
|
GV 2017 GP, L.L.C.
Director |
Sell | 9,349 @ $34.78 | $325,115 | 19,302 | 11/02/2022 | 11/04/2022 | |
|
Yeshwant Krishna
Director |
Sell | 29,326 @ $36.69 | $1.08 M | 4,389,487 | 11/01/2022 | 11/02/2022 | |
|
Yeshwant Krishna
Director |
Sell | 2,377 @ $37.82 | $89,901 | 4,387,110 | 11/01/2022 | 11/02/2022 | |
|
Yeshwant Krishna
Director |
Sell | 260 @ $38.64 | $10,046 | 4,386,850 | 11/01/2022 | 11/02/2022 | |
|
Yeshwant Krishna
Director |
Sell | 23,732 @ $37.91 | $899,588 | 4,448,777 | 10/31/2022 | 11/02/2022 | |
|
Yeshwant Krishna
Director |
Sell | 23,275 @ $38.94 | $906,403 | 4,425,502 | 10/31/2022 | 11/02/2022 | |
|
Yeshwant Krishna
Director |
Sell | 6,601 @ $40.16 | $265,076 | 4,418,901 | 10/31/2022 | 11/02/2022 | |
|
Yeshwant Krishna
Director |
Sell | 88 @ $40.64 | $3,577 | 4,418,813 | 10/31/2022 | 11/02/2022 | |
|
GV 2017 GP, L.L.C.
Director |
Sell | 23,732 @ $37.91 | $899,588 | 4,448,777 | 10/31/2022 | 11/02/2022 | |
|
GV 2017 GP, L.L.C.
Director |
Sell | 23,275 @ $38.94 | $906,403 | 4,425,502 | 10/31/2022 | 11/02/2022 | |
|
GV 2017 GP, L.L.C.
Director |
Sell | 6,601 @ $40.16 | $265,076 | 4,418,901 | 10/31/2022 | 11/02/2022 | |
|
GV 2017 GP, L.L.C.
Director |
Sell | 88 @ $40.64 | $3,577 | 4,418,813 | 10/31/2022 | 11/02/2022 |
Verve Therapeutics, Inc. Frequently Asked Questions
-
Who is on Verve Therapeutics, Inc.'s Insider Roster?
The list of insiders at Verve Therapeutics, Inc. includes Dorval Allison, Yeshwant Krishna, Nickerson Joan, Ashe Andrew D..
-
How much insider selling is happening at Verve Therapeutics, Inc.?
Insiders have sold a total of 2,068 Verve Therapeutics, Inc. shares in the last 12 months for a total of 18,819 sold.
-
Which Verve Therapeutics, Inc. insiders have been selling company stock?
The following insiders have sold Verve Therapeutics, Inc. shares in the last 12 months: Dorval Allison ($6,343), Nickerson Joan ($12,475),
-
How much insider buying is happening at Verve Therapeutics, Inc.?
Insiders have purchased a total of 1.88 M Verve Therapeutics, Inc. shares in the last 12 months for a total of 18.48 M sold.
-
Which Verve Therapeutics, Inc. insiders have been buying company stock?
The following insiders have purchased Verve Therapeutics, Inc. shares in the last 12 months: Yeshwant Krishna ($18.00 M), Ashe Andrew D. ($475,760),